6505--COLESTIPOL HCL 1GM TAB 120CT and DESONIDE 0. 05% CREAM, TOP - 762 TUCSON - AP0181 and AP0182

The Department of Veterans Affairs, Veterans Health Administration Veterans Integrated Service Network 15, through its Network Contracting Office 15 CMOP Division, is procuring two pharmaceutical products: Colestipol HCL 1GM tablets in 120-count bottles and Desonide 0.05% cream in 15-gram units. All responsible sources may submit quotations for consideration, and offerors are required to submit a signed SF1449 form, a price schedule in Excel format, a valid and unexpired state wholesale distributor license demonstrating Drug Supply Chain Security Act (DSCSA) compliance, and a Buy American Act certificate specifying place of manufacture. Vendors failing to provide the state license will be deemed non-compliant. The solicitation emphasizes strict adherence to regulatory requirements, including wholesale distributor licensure verification and DSCSA compliance. Quotations are due by January 30, 2026, and offerors are responsible for monitoring SAM.GOV for any amendments or changes to the solicitation. Interested parties should submit responses via email to Jennifer Coleman at Jennifer.Coleman4@va.gov or call 913-758-9934 for additional information.

This procurement is designated as a Total Small Business Set-Aside under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC code 6505 (Drugs and Biologicals). The pre-solicitation notice was posted on January 23, 2026, with an estimated solicitation issue date of the same day and a response due date of January 30, 2026. The specific quantities required are 1,704 bottles of Colestipol HCL and 5,904 units of Desonide cream, to be delivered to the VA Tucson CMOP facility at 3675 E Britannia Drive, Tucson, Arizona 85706. Delivery is required within 10 days after receipt of order (ARO). No incumbent contractor or award value information is provided in this pre-solicitation notice; however, vendors can reference the RFQ number 36C77026Q0058 for additional details and pricing considerations.